Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

Background SMARCA4 mutations have recently been identified as driving lesions of the ovarian small cell carcinoma of hypercalcemic type (SCCHT). Familial occurrence of this neoplasm was described previously.